NCT06549010

Brief Summary

Perimetry is an essential component in the diagnosis and monitoring of glaucoma. Since the advent of Standard Automated Perimetry (SAP), one of the clinical standards has been the Humphrey Field Analyzer (HFA, Carl Zeiss AG, Oberkochen, Germany). Visual field (VF) testing provided by the HFA is standard-of-care in glaucoma clinics and other ophthalmology and optometry practices. However, the HFA is a large device that does not allow for examination outside the clinic and can be uncomfortable for patients with limited mobility. This study aims to evaluate a novel head-mounted perimeter against the HFA as an alternative method of VF testing. This new perimeter uses a Virtual Reality (VR) headset and a gamified version of VF testing to assess the visual function of healthy eyes and patients. The results of this study will potentially serve as pilot data for the design of a larger study that involves the full assessment of the VR headset and its VF test, based on various testing strategies.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 3, 2024

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

August 2, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

August 12, 2024

Completed
20 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2024

Completed
Last Updated

August 12, 2024

Status Verified

August 1, 2024

Enrollment Period

2 months

First QC Date

August 2, 2024

Last Update Submit

August 8, 2024

Conditions

Keywords

GlaucomaPerimetric testvirtual reality

Outcome Measures

Primary Outcomes (3)

  • Visual field perimetry light sensitivity

    Localized differential light sensitivity threshold measured in decibels (dB)

    1 day

  • Visual field perimetry foveal sensitivity

    Foveal threshold in decibels (dB)

    1 day

  • Visual field perimetry test duration

    Test duration measured in minutes

    1 day

Secondary Outcomes (1)

  • Optical Coherence Tomography (OCT)

    1 day

Study Arms (2)

Healthy subjects

OTHER

30 healthy subjects

Diagnostic Test: Perimetric test

Glaucoma subjects

OTHER

30 glaucoma patients, 10 mild, 10 moderate, 10 severe

Diagnostic Test: Perimetric test

Interventions

Perimetric testDIAGNOSTIC_TEST

This study aims to evaluate a novel head-mounted perimeter against the HFA as an alternative method of VF testing. This new perimeter uses a Virtual Reality (VR) headset and a gamified version of VF testing to assess the visual function of healthy eyes and patients.

Glaucoma subjectsHealthy subjects

Eligibility Criteria

Age25 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • Age range: 25-70 years
  • For normal subjects:
  • Patient is free of any current or prior ophthalmic pathologies that would potentially cause visual field defects: e.g. retina pathology, glaucoma, cataracts, keratoconus
  • No ocular surgery other than cataract surgery within 6 months prior to the study visit
  • For glaucoma subjects:
  • Patient has a diagnosis of primary open-angle glaucoma
  • Patient is free of any other current or prior ophthalmic pathologies that would potentially cause visual field defects.
  • No other ocular surgery other than glaucoma or cataract surgery within 6 months prior to the study visit
  • No IOP lower than 10 mm/Hg or higher than 30 mm/Hg
  • Refractive Error:
  • Sphere = up to -6.00 D to and up +3.00
  • Cylinder = up to -3.00 is common
  • No past refractive eye surgery
  • No Multifocal or phakic (ICLs) IOL; no multifocal CLs
  • One eligible eye
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Illinois College of Optometry / Illinois Eye Institute

Chicago, Illinois, 60616, United States

RECRUITING

Related Publications (4)

  • Montesano G, Bryan SR, Crabb DP, Fogagnolo P, Oddone F, McKendrick AM, Turpin A, Lanzetta P, Perdicchi A, Johnson CA, Garway-Heath DF, Brusini P, Rossetti LM. A Comparison between the Compass Fundus Perimeter and the Humphrey Field Analyzer. Ophthalmology. 2019 Feb;126(2):242-251. doi: 10.1016/j.ophtha.2018.08.010. Epub 2018 Aug 14.

    PMID: 30114416BACKGROUND
  • Marin-Franch I, Turpin A, Artes PH, Chong LX, McKendrick AM, Alawa KA, Wall M. The Open Perimetry Initiative: A framework for cross-platform development for the new generation of portable perimeters. J Vis. 2022 Apr 6;22(5):1. doi: 10.1167/jov.22.5.1.

    PMID: 35385053BACKGROUND
  • Marin-Franch I, Swanson WH. The visualFields package: a tool for analysis and visualization of visual fields. J Vis. 2013 Mar 14;13(4):10. doi: 10.1167/13.4.10.

    PMID: 23492926BACKGROUND
  • Bradley C, Ahmed IIK, Samuelson TW, Chaglasian M, Barnebey H, Radcliffe N, Bacharach J. Validation of a Wearable Virtual Reality Perimeter for Glaucoma Staging, The NOVA Trial: Novel Virtual Reality Field Assessment. Transl Vis Sci Technol. 2024 Mar 1;13(3):10. doi: 10.1167/tvst.13.3.10.

    PMID: 38488433BACKGROUND

MeSH Terms

Conditions

Glaucoma

Condition Hierarchy (Ancestors)

Ocular HypertensionEye Diseases

Study Officials

  • Michael Chaglasian, OD

    Illinois College of Optometry

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Michael Chaglasian, OD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
FACTORIAL
Model Details: 30 healthy subjects 30 glaucoma subjects
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 2, 2024

First Posted

August 12, 2024

Study Start

July 3, 2024

Primary Completion

September 1, 2024

Study Completion

October 1, 2024

Last Updated

August 12, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will share

De-identified data and data analysis will be shared for communication of results and learning conclusions.

Shared Documents
STUDY PROTOCOL, SAP, CSR
Time Frame
The data will submitted for publication in a medical journal, within 3-6 months of completion of the data analysis of the monitored and locked database.
Access Criteria
The trial results will be published in an open-access medical journal.

Locations